Insights

Innovative Therapeutic Focus Pretzel Therapeutics is pioneering first-in-class therapies targeting mitochondrial dysfunction, presenting significant opportunities to collaborate with pharmaceutical companies seeking to expand their portfolio in rare and complex diseases such as mitochondrial and aging-related disorders.

Recent Investment & Funding With substantial backing from investors like Mubadala and the United Mitochondrial Disease Foundation, Pretzel is positioned for accelerated research and development, making it an attractive partner for biotech firms and funding agencies seeking cutting-edge mitochondrial solutions.

Strategic Collaborations Partnerships with SciLifeLab and early engagement with foundation investors indicate an openness to joint ventures and research alliances, providing avenues for companies interested in co-developing diagnostics, therapeutics, or research tools in mitochondrial medicine.

Market Expansion Potential Given the company's focus on wide-ranging diseases—including neurological, metabolic, and muscle disorders—sales opportunities exist across multiple therapeutic areas and patient populations, especially in markets with unmet treatment needs.

Growth & Development Outlook As Pretzel continues to hire senior leadership and present preclinical data at key industry events, there is a clear trajectory of growth and innovation, offering early engagement prospects for vendors, clinical research partners, and commercial partners in the biotech ecosystem.

Pretzel Therapeutics Tech Stack

Pretzel Therapeutics uses 8 technology products and services including BILL, Font Awesome, Floating UI, and more. Explore Pretzel Therapeutics's tech stack below.

  • BILL
    Accounting And Finance
  • Font Awesome
    Font Scripts
  • Floating UI
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • Expensify
    Travel And Expense Management
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • MonsterInsights
    Web Platform Extensions

Media & News

Pretzel Therapeutics's Email Address Formats

Pretzel Therapeutics uses at least 1 format(s):
Pretzel Therapeutics Email FormatsExamplePercentage
FLast@pretzeltx.comJDoe@pretzeltx.com
47%
First@pretzeltx.comJohn@pretzeltx.com
3%
First.Last@pretzeltx.comJohn.Doe@pretzeltx.com
3%
FLast@pretzeltx.comJDoe@pretzeltx.com
47%

Frequently Asked Questions

What is Pretzel Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Pretzel Therapeutics's official website is pretzeltx.com and has social profiles on LinkedInCrunchbase.

What is Pretzel Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Pretzel Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pretzel Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Pretzel Therapeutics has approximately 45 employees across 2 continents, including North AmericaEurope. Key team members include Chief Development Officer (cdo): A. D.Chief Scientific Officer: G. M.Vp Biology: D. E.. Explore Pretzel Therapeutics's employee directory with LeadIQ.

What industry does Pretzel Therapeutics belong to?

Minus sign iconPlus sign icon
Pretzel Therapeutics operates in the Biotechnology Research industry.

What technology does Pretzel Therapeutics use?

Minus sign iconPlus sign icon
Pretzel Therapeutics's tech stack includes BILLFont AwesomeFloating UIYoast SEOExpensifyBootstrapGoogle AnalyticsMonsterInsights.

What is Pretzel Therapeutics's email format?

Minus sign iconPlus sign icon
Pretzel Therapeutics's email format typically follows the pattern of FLast@pretzeltx.com. Find more Pretzel Therapeutics email formats with LeadIQ.

Pretzel Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Our mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology. 

Mitochondria are essential energy-converting cellular organelles found in nearly every cell type throughout the body. Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondrial dysfunction also plays an important role in more common diseases, including aging-related disorders. 

At Pretzel, we are developing first-in-class therapeutics that can address mitochondrial dysfunction at its roots. By taking aim at the genetic drivers of mitochondrial dysfunction, we believe our approach could be effective across a wide range of diseases which lack meaningful treatment options today.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Pretzel Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Pretzel Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.